Supplemental Experimental Procedures
Mice. Nr2f6-deficient mice (Warnecke et al., 2005) back-crossed on C57BL/6 background were used. Wild-type C57BL/6 TRAMP (Tg(TRAMP)8247Ng) mice were crossed into Nr2f6-deficient mice to generate Nr2f6 -/-TRAMP and Nr2f6 +/+TRAMP mice. Rag1 -/-(B6.129S7- (Clone HRPN; BE0088) control (all from BioXCell, USA) every 3 days starting from day 1 of B16-OVA challenge according to (Zou et al., 2014) .
Therapeutic adoptive cell transfer. C57BL/6 wild-type mice at 8 to 12 weeks of age were tissues from sacrificed mice were prepared by mechanical disruption followed by digestion for 45 min with collagenase D (2.5 mg/ml; Roche, 11088858001) and DNase I (1 mg/ml; Roche, 11284932001) at 37°C. Digested tissues were incubated 5 min at 37°C with EDTA (0.5 M) to prevent DC/T cell aggregates and mashed through a 100-µm filter and a 40-µm filter. Cells were washed, and resuspended in either PBS+2% FCS or IMDM complete medium (10% FCS, 2 mM L-glutamine, and 50 U/ml penicillin/streptomycin).
Ex vivo CD8
+ T cell analysis. CD8 + T cells were isolated using either the mouse CD8 T Cell Isolation Kit II (Miltenyi Biotec, or the human CD8 + T Cell Isolation Kit (Miltenyi Biotec, . Activation of CD8 + T cells was performed in complete IMDM medium in the presence of plate-bound 2C11 (made in house) for mouse or OKT3 for human anti-CD3 (5 µg/ml, eBiosciences, 16-0037) and soluble mouse or human anti-CD28
(1 µg/ml, BD, 553294). Cells were harvested at the indicated time points. For survival and apoptosis assays, spleens and lymph nodes were isolated from Nr2f6 +/+ and Nr2f6 -/-mice.
Single cell suspensions were pooled and stained with fluorochrome-labelled antibodies recognizing mouse CD4 (GK1.5) or mouse CD8a (53-6.7, both from BioLegend), respectively. To exclude dead cells, 12.5µg/mL DAPI was added. Cells were sorted on a BD FacsAria TM III Cell sorter (BD Biosciences). Sorted T cells were cultured at a concentration of 1x10 6 /mL in Roswell Park Memorial Institute (RPMI) 1640 medium (PAA; E15-039), supplemented with 10% FCS, 2 mM L-Glutamine, 1% Penicillin plus Streptomycin (10.000 U/mL Penicillin and 10 mg/mL Streptomycin in 0.9% NaCl), 5 x 10 -5 M 2-mercaptoethanol, 50µg/mL Gentamicin, 100µM non-essential amino acids (Gibco, 1091607) and 1 mM sodium pyruvate (Gibco, 1046485). Apoptosis was assessed after 48 hours in culture using Annexin V Apoptosis Detection Kit eFluor® 450 (eBioscience).
Chromatin immunoprecipitation.
ChIP assay was performed with a ChIP assay kit according to the recommendations of the manufacturer (Imgenex) in combination with the Cold Spring Harbor protocol (Carey et al., 2009 ) and previously described methods (Hermann-Kleiter et al., 2012) . Briefly, Nr2f6 +/+ and Nr2f6-deficient CD3 + T cells were isolated untouched using the Pan T Cell Isolation Kit II mouse (Miltenyi Biotech, Gene expression analysis and MLPA. Total RNA was isolated using the RNeasy® Mini Kit (Quiagen). First-strand cDNA synthesis was performed using oligo(dT) primers (Promega) with the Qiagen Omniscript RT kit, according to the instructions of the supplier and as described previously (Hermann-Kleiter et al., 2012) . Expression analysis was performed using real-time PCR with an ABI PRIM 7000 or ABI PRIM 7500fast Sequence Detection System with TaqMan gene expression assays (Applied Biosystems); all expression patterns were normalized to Gapdh. Multiplex Ligation-dependent Probe Amplification (MLPA) was performed using the SALSA® MLPA® EK1-RT kit purchased from MRC-Holland and used according to the manufacturer's instructions. Briefly, RNA was isolated, using the Quick-RNA™ MicroPrep (Zymo Research, #R1051) according to the manufacturer's instructions.
Specific mRNAs were reversely transcribed into cDNA and bound by two oligonucleotides consequently ligated by a heat stable ligase forming one probe. Each probe gives rise to an amplification product of unique length, separated by capillary sequencer (Genescan). 2C11) and 1µg/ml anti-CD28 soluble in the presence of 5ng/ml recombinant mouse TGF-b and recombinant 20ng/ml hIL-2. Th1 polarization was performed with 5µg/ml anti-CD3 and 1µg/ml anti-CD28 in the presence of 10ng/ml mIL-12 and 5µg/ml anti-IL-4 (eBiosciences).
Analysis was performed with GeneMapper (Applied Biosystems GmbH
Gel mobility-shift assay. Electromobility assay was performed as described previously (Hermann-Kleiter et al., 2008 Statistics. Data were analyzed using Prism 5.03 software (GraphPad Software).
Experiments were repeated at least two or three times. Data are represented as indicated (either the mean ± SEM or ± SD) for all figure panels in which error bars are shown. The P values were assessed using two-tailed unpaired student's t-test, log rank test, or ANOVA. A P value of less than 0.05 was considered statistically significant. *p<0.05; **p<0.01; ***p<0.001.
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